These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3024529)

  • 41. Latent collagenase of rheumatoid synovial fluid is not of granulocytic origin.
    Wize J; Wierzchowska E; Wojtecka-Lukasik E; Garwolińska H; Maśliński S
    Biochim Biophys Acta; 1984 Oct; 801(3):360-4. PubMed ID: 6091771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synovial fluid from rheumatoid arthritis patients contains sufficient levels of IL-1 beta and IL-6 to promote production of serum amyloid A by Hep3B cells.
    McNiff PA; Stewart C; Sullivan J; Showell HJ; Gabel CA
    Cytokine; 1995 Feb; 7(2):209-19. PubMed ID: 7780041
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Connective tissue activation. X. Current studies of the process and its mediators.
    Castor CW; Lewis RB
    Scand J Rheumatol Suppl; 1975; 12():41-54. PubMed ID: 1084567
    [No Abstract]   [Full Text] [Related]  

  • 44. CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes.
    Zhu P; Lu N; Shi ZG; Zhou J; Wu ZB; Yang Y; Ding J; Chen ZN
    Arthritis Res Ther; 2006; 8(2):R44. PubMed ID: 16507143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Collagenase reserves in polymorphonuclear neutrophil leukocytes from synovial fluid and peripheral blood of patients with rheumatoid arthritis.
    Konttinen YT; Lindy O; Kemppinen P; Saari H; Suomalainen K; Vauhkonen M; Lindy S; Sorsa T
    Matrix; 1991 Aug; 11(4):296-301. PubMed ID: 1656176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Partial purification and characterization of the high molecular weight latent collagenase from human leukocytes.
    Cohen G; Baici A; Fehr K; Böni A
    Scand J Rheumatol; 1980; 9(1):44-8. PubMed ID: 6246573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Collagenase of human leukocytes. Its characteristics, function and regulatory mechanisms].
    Grabowska-Bochenek R; Drózdz M
    Postepy Hig Med Dosw; 1991; 45(3-4):199-214. PubMed ID: 1658760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A collagenolytic system produced by primary cultures of rheumatoid nodule tissue.
    Harris ED
    J Clin Invest; 1972 Nov; 51(11):2973-6. PubMed ID: 4342958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phagocytic function of polymorphonuclear leukocytes in rheumatic diseases.
    Turner RA; Schumacher R; Myers AR
    J Clin Invest; 1973 Jul; 52(7):1632-5. PubMed ID: 4578156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T lymphocyte subpopulations defined by monoclonal antibodies in synovial fluid of patients with rheumatic disease.
    Nilsson E; Biberfeld G
    J Clin Lab Immunol; 1982 Nov; 9(2):93-7. PubMed ID: 6984082
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synovial fluid alkaline phosphatase.
    Cimmino MA; Dato G; Cutolo M
    Arthritis Rheum; 1987 Feb; 30(2):235-7. PubMed ID: 3493782
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
    Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human collagenases: comparative and immunolocalization studies.
    Woolley DE
    Ciba Found Symp; 1979; (75):69-86. PubMed ID: 233354
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for the presence of a complex of collagenase with alpha2-macroglobulin in human rheumatoid synovial fluid: a possible regulatory mechanism of collagenase activity in vivo.
    Abe S; Nagai Y
    J Biochem; 1973 Apr; 73(4):897-900. PubMed ID: 4124242
    [No Abstract]   [Full Text] [Related]  

  • 56. Vertebrate collagenase: further characterization and the significance of its latent form in vivo.
    Nagai Y
    Mol Cell Biochem; 1973 Jun; 1(2):137-45. PubMed ID: 4127759
    [No Abstract]   [Full Text] [Related]  

  • 57. Cellular interactions and control of collagenase secretion in the synovium.
    Krane SM; Amento EP
    J Rheumatol Suppl; 1983 Dec; 11():7-12. PubMed ID: 6321722
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of cartilage proteoglycans on human collagenase activities.
    Woolley DE; Evanson JM
    Biochim Biophys Acta; 1977 Mar; 497(1):144-50. PubMed ID: 191088
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways.
    Milner JM; Elliott SF; Cawston TE
    Arthritis Rheum; 2001 Sep; 44(9):2084-96. PubMed ID: 11592371
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A review of collagen metabolism and breakdown.
    Lowther DA
    Aust N Z J Med; 1978; 8 Suppl 1():7-11. PubMed ID: 215115
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.